Evaluation of the Positioning of the Dynacup Cup "One C" Versus "Standard Dynacup"
NCT ID: NCT06053060
Last Updated: 2023-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
300 participants
INTERVENTIONAL
2021-11-21
2023-03-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These ceramic fractures require complex revision surgery, which brings complications, exposing patients to the risk of third-body wear and tear related to persistent post-surgical debris. They are frequently due to an incorrect assembly of the ceramic causing intraoperative or early postoperative rupture. To fix this, manufacturers have developed pre-assembled cups in the factory. The Dynacup One C cup developed by Corin® corresponds to the pre-assembled version of the Dynacup cup, making it possible to eliminate the risk of anomaly during intraoperative assembly linked to the human factor and to offer patients with very small cups an adapted ceramic implant. A single study with a small sample compared the two implants (pre-assembled version \[vs\] modular version) clinically, radiologically and functionally without showing any significant difference. The lack of data in the literature comparing these two implants motivated us to conduct a randomized comparative study on a large sample of patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Ambispective Study on HYPE Cups Associated With HIPER Liner
NCT06465940
A Post Market Surveillance Study About the MONOCER Cup
NCT05785364
Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair
NCT02062437
Dual-mobility Cups Compared to Unipolar Cups on Dislocation and Cost-effectiveness After Primary Total Hip Arthroplasty.
NCT04031820
Bone Fixation of Mpact Double Mobility Cup
NCT02850575
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After randomization, a preoperative radiograph with a calibration ball will be taken to plan the prosthesis and identify the characteristics of the operated hip.
An x-ray of the pelvis with a 28 mm ball will be carried out the day after the intervention according to the same preoperative procedures in order to measure the postoperative radiographic parameters.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Dynacup
Hip arthroplasty with a standard Dynacup cup
Randomisation Standard Dynacup or Dynacup One C
Randomisation
Dynacup One C
Hip arthroplasty with a cup Dynacup One C
Randomisation Standard Dynacup or Dynacup One C
Randomisation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Randomisation Standard Dynacup or Dynacup One C
Randomisation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication for hip arthroplasty with a Dynacup One C or standard Dynacup cup
* Patient informed of the study and signed a consent form
Exclusion Criteria
* Indication of a friction couple other than ceramic-ceramic
* Contraindication or the technical impossibility of implanting an impacted acetabular component
* Pregnant or breastfeeding women.
* Minor patients aged \< 18 years
* Subjects not affiliated to the national health insurance or to an equivalent insurance
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe Hospitalier Diaconesses Croix Saint-Simon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SMARMOR
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simon MARMOR, MD
Role: PRINCIPAL_INVESTIGATOR
Groupe Hospitalier Diaconesses Croix Saint-Simon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hospitalier Dianconesses croix saint Simon
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID RCB : 2020-A02843-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.